Artelo Biosciences Inc Financial Flexibility Index
Artelo Biosciences Inc financial flexibility index. Artelo Biosciences Inc (ARTL) has a Financial Flexibility Index of -3.44x as of June 2026. Free cash flow of $-5.03 Million (operating CF $-5.03 Million minus capex $0.00) represents -3% of total liabilities ($1.46 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Artelo Biosciences Inc (2015–2025)
Financial flexibility index of Artelo Biosciences Inc from 2015 to 2025. Historical Financial Flexibility Index trend for Artelo Biosciences Inc across 11 annual periods. Explore Artelo Biosciences Inc (ARTL) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Artelo Biosciences Inc Financial Flexibility Index by Year (2015–2025)
Artelo Biosciences Inc financial flexibility index by year from 2015 to 2025. Year-by-year free cash flow to debt coverage for Artelo Biosciences Inc. For the full cash flow conversion analysis, see ARTL cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.09x | $-8.52 Million | $-8.52 Million | $4.07 Million | ▲ +53.9% |
| 2024 | -4.54x | $-8.35 Million | $-8.35 Million | $1.84 Million | ▲ +28.7% |
| 2023 | -6.36x | $-8.21 Million | $-8.21 Million | $1.29 Million | ▲ +18.9% |
| 2022 | -7.84x | $-8.01 Million | $-8.01 Million | $1.02 Million | ▲ +24.3% |
| 2021 | -10.36x | $-6.14 Million | $-6.14 Million | $593.00K | ▼ -82.3% |
| 2020 | -5.68x | $-2.85 Million | $-4.35 Million | $501.00K | ▼ -349.1% |
| 2019 | -1.26x | $-1.29 Million | $-2.79 Million | $1.02 Million | ▲ +58.2% |
| 2018 | -3.02x | $-1.61 Million | $-1.61 Million | $531.97K | ▲ +58.8% |
| 2017 | -7.34x | $-215.98K | $-216.82K | $29.44K | ▼ -623.1% |
| 2016 | -1.01x | $-17.64K | $-18.49K | $17.39K | ▲ +86.1% |
| 2015 | -7.28x | $-12.66K | $-13.50K | $1.74K | — |